All Coursera Quiz Answers

Medical Technology And Evaluation Week 1 Quiz Answer

by Niyander

Hello friends in this article i am gone to share Medical Technology And Evaluation Week 1 Quiz Answer with you..

Course link: https://www.coursera.org/learn/healthcare-medical-technology

Medical Technology and Evaluation by University of Minnesota

Also visit this link:  Medical Technology And Evaluation Week 4 Quiz Answer

 

Medical Technology Assessment Environment

Question 1) Which of the following is a use a potential user of medical technology evaluation results?
  • Insurers.
  • Manufacturers.
  • Health care providers.
  • All of the above.
Question 2) True or False: A medical technology evaluation is just a pricing project.
  • True
  • False
Question 3) How can a new technology with lower costs lead to higher health care expenditures?
  • No new technologies have lower costs.
  • The technology will only reduce expenditures.
  • The technology is effective and used by a larger population than the current technology.
  • The technology has better outcomes compared to the current technology.
Question 4) What is the regulatory reason that medical technology evaluation evidence is needed?
  • Pricing.
  • Only payment/reimbursement.
  • Venture capitalist investments.
  • Marketing approval and payment/reimbursement.
Question 5) Which of the FDA approval phases occurs after FDA approval?
  • Phase I
  • Phase IV
  • Phase III and IV
  • None
Question 6) True or False: Once approved a new drug can only be prescribed for what it was approved to treat.
  • True
  • False
Question 7) Approximately what percent of new medical devices require a Pre-Market Approval (PMA)?
  • 90 percent
  • 0 percent
  • 100 percent
  • 10 percent
Question 8) What is the next step after a drug is approved by the FDA?
  • File an NDA.
  • Design the packaging.
  • Conduct a clinical trial.
  • Get insurers to pay/reimburse.
Question 9) What aspects of medical care is covered by Medicare Part A?
  • Prescription drugs.
  • Outpatient services.
  • Inpatient hospital care.
  • Patient out-of-pocket costs.
Question 10) True or False: Patients may have higher cost sharing obligations for the more expensive brand name version of a drug.
  • True
  • False